Athenahealth, Inc.
ATHN
ATHN was delisted on the 11th of February, 2019.
226 hedge funds and large institutions have $5.35B invested in Athenahealth, Inc. in 2017 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 77 increasing their positions, 75 reducing their positions, and 37 closing their positions.
9% more capital invested
Capital invested by funds: $4.89B → $5.35B (+$457M)
3% more repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 75
6% less funds holding
Funds holding: 240 → 226 (-14)
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
19% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 37
24% less call options, than puts
Call options by funds: $51.5M | Put options by funds: $67.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$228M |
| 2 |
BlackRock
New York
|
+$186M |
| 3 |
Morgan Stanley
New York
|
+$46.4M |
| 4 |
ClearBridge Investments
New York
|
+$40.5M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$39.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$108M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$89.9M |
| 3 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$31.6M |
| 4 |
Two Sigma Investments
New York
|
-$27.1M |
| 5 |
Sands Capital Management
Arlington,
Virginia
|
-$24.7M |
ATHN Hedge Fund Activity: Q1 2017 in Review
226 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Athenahealth, Inc. (ATHN) for Q1 2017, worth a combined $5.35B — up 9.3% from $4.89B a quarter earlier.
Sellers outnumbered buyers: 37 funds closed out of ATHN and 30 opened new positions — a net loss of 7 holders — while 75 trimmed existing stakes and 77 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $228M. The largest seller was Capital Research Global Investors, cutting an estimated $108M.
- 226 institutional investors held Athenahealth, Inc. (ATHN) as of Q1 2017, down from 240 in Q4 2016.
- Funds reported $5.35B of Athenahealth, Inc. stock for Q1 2017, up 9.3% quarter-over-quarter.
- 30 funds opened new Athenahealth, Inc. positions in Q1 2017 and 37 closed out, a net change of -7 holders.
- The largest Athenahealth, Inc. buyer in Q1 2017 was T. Rowe Price Associates, an estimated $228M added.
- The largest Athenahealth, Inc. seller in Q1 2017 was Capital Research Global Investors, an estimated $108M sold.
Based on aggregated 13F filings for Q1 2017.